drugset / Trial / NCT05941494

Cerebral Flow-metabolism Coupling During Adult Surgery

NCT05941494

Phase 4 Unknown 80 enrolled Jason Chui
RandomizedFactorialDouble-blindTreatment

Summary

The brain is a highly active organ that requires a large blood flow to function properly. Normally, blood flow is tightly linked to the brain's energy demands. However, during surgery, anesthesia can affect this relationship in different ways. Some types of anesthesia can decrease blood flow to the brain, while others can increase it. Anesthesiologists need to be careful to maintain adequate blood flow to the brain during surgery, especially when blood pressure drops. Drugs may be used to increase blood pressure, but some of these drugs can also affect blood flow to the brain. It is still unclear how to best maintain blood flow to the brain during surgery and how different types of anesthesia and drugs affect this process. The study aims to assess the clinical utility of a new technique that uses light-based neuromonitoring to measure changes in cerebral blood flow and metabolism. The investigators will recruit 80 adult patients undergoing surgery under general anesthesia and randomize them into one of four groups to evaluate the effects of different anesthetic agents and vasopressors on brain hemodynamics and metabolism. The study will include patients over 18 years of age with no history of neurological conditions, substance abuse, or contraindications to cerebral oximetry devices or specific anesthetic agents. The patients will receive standard anesthesia care and be monitored with our light-based neuromonitoring system. This study aims to demonstrate the device's ability to detect changes in cerebral hemodynamic parameters related to anesthesia induction and systemic hypotension. This study will also evaluate the effects of anesthetic maintenance agents and vasopressors on cerebral hemodynamics and neurovascular coupling.

Timeline

Start
2023-10-03
Primary completion
2025-12-31
Completion
2025-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ephedrine Small molecule 10 mg
Subject Ephedrine Small molecule 50 mg
Subject Phenylephrine Small molecule 10 ug
Subject Phenylephrine Small molecule 40 ug
Subject Propofol Small molecule 150 mg/kg
Subject Propofol Small molecule 200 mg/kg
Subject Sevoflurane Other / unclassified 1 unknown

Indications

No indication recorded.